Recent findings from Marktlink, an independent international M&A advisory firm with a UK base in Manchester, indicate that 47% of SME leaders have contemplated acquiring another business in the past year. Notably, nearly two thirds (64%) of these leaders plan to make a purchase within the next five years.
Bringing together drug discovery company Evotec, pharmaceutical company Bristol Myers Squib, and leading British universities, the $20 million (£16 million) beLAB1407 partnership seeks to identify novel disease modifying therapeutic targets and platforms early on, and to develop them into new biotech spinouts.

















